|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
4/2021
vol. 96 abstract:
Original paper
Non-alcoholic fatty liver disease (NAFLD) spectrum in children with type 1 diabetes mellitus evaluated with non-invasive fibrosis score and instrument: A cross-sectional study
Abeer M.N.E. Abd ElBaky
1
,
Nagwa A. Ismail
1
,
Maha M. Abo-Hashesh
1
,
Tarek F. ElShaer
1
,
Shereen H. Abd El Aziz
1
,
Inas Abdel Rasheed
1
Pediatr Pol 2021; 96 (4): 223–230
Online publish date: 2022/01/11
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Aim of the study
The aim of the study was to evaluate NAFLD spectrum in children with type 1 of diabetes mellitus (T1DM) by simple fibrosis scores and advanced biochemical markers in association with abdominal ultrasonography (US), Acoustic radiation force impulse elastography (ARFI) and comparing their results. Material and methods A case-control study was conducted on 142children and adolescents with T1DM and79 subjects as controls. Through medical history, clinical examination, and laboratory assessment including glycosylated hemoglobin (HbA1c) levels and liver enzymes including AST and ALT were carried out. Calculation of simple fibrosis scores (AST/ALT ratio, AST to platelet ratio index (APRI), fibrosis (FIB)-4 index, paediatric NAFLD fibrosis index (PNFI) were done. Assessment of advanced biochemical markers including hyaluronic acid (HA) , amino terminal pro peptide of type III collagen (PIIINP) and tissue inhibitor of metalloproteinase 1 (TIMP-1) levels. Also, ELF test were calculated. Results Data of non-invasive fibrosis score, there were statistically significant difference between cases and controls in fibrosis 4 score, Discriminant score also ratio of AST to ALT value (p = 0.009, 0.000 and 0.019) respectively. Also, regarding advanced biochemical markers and ELF score, there were a high statistically significant difference in TMP, Hyaluronic acid and ELF(p = 0.00, 0.044 and 0.00) respectively. Conclusions Our results support that there are available non-invasive biomarkers for hepatic affection in children with T1DM. Obtained results support that there is a going on process in diabetic children could be assessed by AST/ALT ratio, FIB-4 index and ELF Score with performing abdominal sonography while ARFI needed in more advanced stage. keywords:
nonalcoholic fatty liver disease (NAFLD), type 1 diabetes mellitus, fibrosis (FIB)-4 index, paediatric NAFLD fibrosis index (PNFI) |
POLSKI
